University of Texas M D Anderson Cancer Center P2C — Houston, Texas

University of Texas M D Anderson Cancer Center P2C is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Texas M D Anderson Cancer Center P2C has participated in 1 clinical trials.

Therapeutic areas: Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Sponsors: National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

• The University of Texas MD Anderson Cancer Center /ID# 277929
• UT Health/ Memorial Hermann Hospital
• University of Texas Vanguard Urologic Research Foundation
• Anxiety and Health Research Lab, Substance Use Treatment Clinic, University of Houston
• Texas Children's Hospital West Campus
• The Methodist Hospital Houston
• The University Of Texas at Houston
• Houston Methodist Hospital - 6565 Fannin St
• Ben Taub General Hospital / Baylor College of Medicine/Harris Health System
• Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street
• The Methodist Hospital Research Institute; Academic Office of Clinical Trials
• University of Texas Health Sciences Center at Houston - Center for Advanced Heart Failure

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas M D Anderson Cancer Center P2C?

University of Texas M D Anderson Cancer Center P2C has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas M D Anderson Cancer Center P2C conducted?

University of Texas M D Anderson Cancer Center P2C has 1 clinical trials on record. Their work covers Metastatic Ureter Carcinoma, Metastatic Urethral Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7.

Is University of Texas M D Anderson Cancer Center P2C accredited by Crixeo Clinical Trials?

University of Texas M D Anderson Cancer Center P2C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas M D Anderson Cancer Center P2C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.